The retail sector delivered a mixed performance during the festive season, with select pockets emerging as bright spots, ...

Dr Reddy’s share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to ’Buy’ with a target of ...

Dr. Reddys Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate the ...

The surge in Dr. Reddy's share followed an upgrade by domestic brokerage Nuvama, which raised its rating on the stock to 'Buy ...

Nuvama assigned a target price of Rs 1,553 per share on Dr. Reddy's stock, implying an upside of 14.8% from the previous ...

Mixed Q3FY25 outlook for retail industry with jewellery and value retail leading growth, footwear and apparel showing ...

Sagar Doshi of Nuvama Professional Clients Group recommends these three stocks today- Oil and Natural Gas Corporation Ltd ...

Nuvama maintains a defensive portfolio, overweight in private banks, insurance, and sectors like pharma and cement, while ...

The report said "Nifty EPS is likely to grow 2 per cent (versus 4 per cent in H1FY25)-posing downgrade risks to H2FY25 consensus estimate of mid-teens growth".

Domestic passive mutual fund (MF) schemes will have to sell around Rs 1,500 crore worth of ITC Hotels shares once the ...

OrbiMed-backed Laxmi Dental on Wednesday said it has fixed the price band at ₹407-428 per share for ₹698 crore initial public ...

Non-life insurers reported a marginal decline in premiums in December due to a revision in premium accounting norms by the ...